View Older Stories View More Recent Stories

Dec 13, 2016 06:33AM Chardan Capital Markets Downgrades Arbutus Biopharma (ABUS) to Neutral; Safety Risk Overwhelms Promising Efficacy
Dec 13, 2016 06:26AM Chardan Capital Markets Starts HealthEquity, Inc (HQY) at Buy
Dec 12, 2016 09:30AM Pre-Open Stock Movers 12/12: (AKAO) (AIQ) (CSOD) Higher; (OPHT) (ALXN) (VIAB) Lower (more...)
Dec 12, 2016 09:00AM PharmaCyte Biotech Secures Funding Opportunity for Pancreatic Cancer Clinical Trial
Dec 12, 2016 06:37AM Regeneron (REGN) Gains Early on Ophthotech Wet AMD Failure
Dec 12, 2016 06:10AM Chardan Capital Markets Downgrades Ophthotech Corp (OPHT) to Neutral
Dec 12, 2016 06:05AM Chardan Capital Markets Upgrades Regeneron Pharma (REGN) to Neutral
Dec 7, 2016 04:52PM Palatin Technologies Closes on $16.5 Million Financing
Dec 6, 2016 09:03AM Chardan Capital Markets Reiterates Buy on Eyegate Pharma (EYEG) Following Study Results
Dec 5, 2016 09:12AM Chardan Capital Markets Reiterates Buy on Vuzix Corp. (VUZI)
Dec 5, 2016 08:30AM Chardan Capital Markets Positive on Alnylam (ALNY) as ASH Data Reinforces Potential for RNAi Across Hemophilia and AIP
Dec 2, 2016 10:05AM Vuzix Announces Closing of $14,500,000 Common Stock Offering
Dec 1, 2016 04:16PM VBL Therapeutics (VBLT) Reports $20M at the Market Offering of Ordinary Shares
Dec 1, 2016 08:21AM Palatin Technologies (PTN) Prices $16.5M Common Stock, Warrants Offering
Dec 1, 2016 08:20AM Palatin Technologies Announces Pricing of Public Offering of Common Stock and Warrants
Nov 30, 2016 04:54PM Palatin Technologies (PTN) Confirms Proposed Offering of Common Stock and Warrants
Nov 30, 2016 04:36PM Palatin Technologies Announces Proposed Public Offering of Common Stock and Warrants
Nov 30, 2016 10:35AM Notable Analyst Rating Changes 11/30: (UNH) (CE) (GS) Upgraded; (GRA) (FCX) (DLTH) Downgraded
Nov 30, 2016 06:33AM Alnylam Pharmaceuticals (ALNY) PT Raised to $89 at Chardan Capital Markets Following Arrowhead's RNAi Program Discontinuations
Nov 30, 2016 06:25AM Chardan Capital Markets Starts WageWorks (WAGE) at Buy
Nov 30, 2016 06:23AM Chardan Capital Markets Upgrades Arbutus Biopharma (ABUS) to Buy Amid Arrowhead Hepatitis B Program Discontinuations
Nov 30, 2016 06:19AM Chardan Capital Markets Downgrades Arrowhead Research (ARWR) to Neutral on EX-1 RNAi Program Discontinuations
Nov 29, 2016 09:07AM Vuzix Corp. (VUZI) to Offer 2M Shares of Common Stock for Proceeds of $14.5M
Nov 29, 2016 09:00AM Vuzix Announces $14,500,000 Common Stock Offering
Nov 29, 2016 08:31AM Chardan Capital Markets Raises Price Target on Amicus Therapeutics (FOLD); Reiterates Buy
Nov 17, 2016 08:52AM Chardan Capital Markets Remains Bullish on Vuzix Corp. (VUZI) as Intel Steps Back Relationship
Nov 16, 2016 10:49AM Notable Analyst Rating Changes 11/16: (DIS) (FOSL) (PAAS) Upgraded; (NOK) (WDR) (NE) Downgraded
Nov 16, 2016 06:15AM Chardan Capital Markets Starts Teladoc (TDOC) at Buy; Sees 40% Upside
Nov 15, 2016 09:51AM uniQure (QURE) PT Cut to $12 at Chardan Capital Markets; 'Buy' Maintained on Simplification
Nov 15, 2016 09:04AM Chardan Capital Markets Reiterates Buy on Vuzix Corp. (VUZI) Following 3Q
Nov 14, 2016 07:51AM NICE Systems (NICE): Chardan Reiterates Buy After Strong Earnings But Before InContact Combination - Chardan
Nov 7, 2016 07:37AM Regeneron (REGN): Reluctance To Discuss Pricing Causes a PT Revision - Chardan
Nov 7, 2016 06:23AM Spark Therapeutics (ONCE) PT Lowered 14% at Chardan Capital Markets as They See Better Value Elsewhere in AAV GT
Nov 4, 2016 10:27AM Notable Analyst Rating Changes 11/4: (ACHN) (MMC) (HCP) Upgraded; (AXL) (BRO) (WFM) Downgraded
Nov 4, 2016 07:12AM Chardan Capital Markets Maintains Bullish View on Cogent (COGT) on Expected Strong Revenue Growth and Margin Expansion
Nov 4, 2016 06:33AM Chardan Capital Markets Upgrades Achillion Pharmaceuticals (ACHN) to Neutral Following Underperformance
Nov 3, 2016 11:16AM Achillion Pharmaceuticals (ACHN) Sell Rating Reiterated at Chardan Capital Markets Amid ACH-4471 Risks
Nov 3, 2016 06:53AM Buy The KEYW Holding (KEYW) on Weakness - Chardan Capital Markets
Oct 28, 2016 11:25AM Chardan Capital Markets Downgrades Opexa Therapeutics (OPXA) to Neutral
Oct 28, 2016 07:42AM Chardan Capital Markets Starts Astrotech Corporation (ASTC) at Buy
Oct 25, 2016 10:10AM Notable Analyst Rating Changes 10/25: (MKC) (FE) (CHK) Upgraded; (VFC) (ARIA) (OCN) Downgraded
Oct 25, 2016 09:05AM Pre-Open Stock Movers 10/25: (SAEX) (CWEI) (SWFT) Higher; (DPRX) (CRBP) (UA) Lower (more...)
Oct 25, 2016 08:28AM UPDATE: Chardan Capital Markets Starts Clovis Oncology (CLVS) at 'Sell' With Price Target of $15
Oct 19, 2016 11:50AM 22nd Century Group Announces Closing of $11.4 Million Above-Market Registered Direct Offering
Oct 17, 2016 08:38AM PlacementTracker Publishes Q3 2016 Private Placement Market League Tables
Oct 14, 2016 09:15AM Inventergy Announces Closing of $6.0 Million Public Offering
Oct 14, 2016 08:46AM 22nd Century Group (XXII) Enters $11.4M Share Registered Direct Offering
Oct 14, 2016 08:45AM 22nd Century Group Announces Above-Market Offering for $11.4 Million
Oct 14, 2016 07:34AM Chardan Capital Markets Upgrades Arbutus Biopharma (ABUS) to Neutral
Oct 10, 2016 09:43AM Notable Mergers and Acquisitions 10/10: (CPN) (PRMW) (LLL) (AYA)
View More Recent Stories View Older Stories